Yea I haven't been able to bring myself to sell my shares. Even though the exec and BOD are so terrible. A culture of over-promise and under-deliver with the clinical development, coupled with being coy about sub-optimal results (thinking IV).Can't believe they actually claim to aim to start 2 (or is it 1?) phase 3 trials later this year.
(20min delay)